Stephen Lowe

New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol

M. Woolrich, R. Henson, K. Singh, 2021, BMJ Open.

Validation of a multiplex assay for simultaneous quantification of amyloid-β peptide species in human plasma with utility for measurements in studies of Alzheimer's disease therapeutics.

H. Vanderstichele, R. Dean, F. Martényi, 2012, Journal of Alzheimer's disease : JAD.

New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol

M. Woolrich, R. Henson, V. Raymont, 2022, BMJ Open.